takeda_global_hq

Takeda completes construction of new global headquarters in Tokyo

pharmafile | March 21, 2018 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo 

Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital of Tokyo, named inventively as “Takeda Global Headquarters”.

The completion of the development, which was conducted as part of the “Nihonbashi-honcho 2nd District Project”, was marked by a ceremony attended by Christophe Weber, President and CEO of Takeda.

The building is situated in the same district which Takeda has operated out of for over 100 years and will assume the functionality of the company’s current headquarters in the city, acting as its flagship base to lead Takeda’s operations in 70 countries across the world.

The building is 24 floors tall reaching 124 metres in height, with four basement floors and has been designed to “further enhance connectivity between individuals and across businesses, while encouraging creativity in work”. Floors 4 to 24 will feature office space, while the first basement to the second floor will feature facilities including a gym, conference rooms and restaurants, all open to the public.

Matt Fellows

Related Content

robina-weermeijer-ihfopazzjhm-unsplash_5

MHRA approves Takeda’s Hyqvia for chronic inflammatory demyelinating polyneuropathy treatment

Takeda has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing …

Takeda and ImmunoGen collaborate for development and commercialisation of Elahere in Japan

ImmunoGen has announced that it has entered into an exclusive collaboration with Takeda Pharmaceutical Company …

FDA approves IMIDEX’s AI-powered device VisiRad XR

The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …

Latest content